Skip to search formSkip to main contentSkip to account menu

DepoCyt

Known as: Depo-Cyt, DepoFoam Encapsulated Cytarabine 
National Institutes of Health

Related topics

Related topics

2 relations
CytarabineCytarabine liposome

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Safety of liposomal cytarabine CNS prophylaxis in children, adolescent and young adult hematopoietic stem cell transplant recipients with acute leukemia and non-Hodgkin lymphoma
Safety of liposomal cytarabine CNS prophylaxis in children, adolescent and young adult hematopoietic stem cell transplant… 
2015
2015
HiDAC (High-Dose Ara-C; Cytarabine; Cytosine Arabinoside; Cytosar-U; Depocyt)
Ara-C remains one of the most effective drugs used in the treatment of acute leukemia and other hematopoietic malignancies. In… 
Review
2015
Review
2015
Neoplastic Myelopathies
Purpose of Review:Involvement of the spinal cord by cancer is seen in 5% to 10% of all patients with cancer. This article reviews… 
2012
2012
Unusual spheroids in cerebrospinal fluid
We report on a case of AIDS-related plasmablastic lymphoma with clinical suspicion of meningeal relapse in a 43-year-old male… 
2011
2011
Response to intrathecal infusions of Depocyt® in secondary diffuse leptomeningeal gliomatosis. A case report.
UNLABELLED Secondary diffuse leptomeningeal gliomatosis, in which a glioma of the brain or spinal cord infiltrates the… 
Review
2009
Review
2009
Safety of Liposomal Cytarabine Prophylaxis in Pediatric Bone Marrow Transplant (BMT) Recipients with Acute Leukemia (AL) and Non Hodgkin Lymphoma (NHL) at High Risk of Cns Relapse
2008
2008
DepoFoam® Multivesicular Liposomes for the Sustained Release of Macromolecules
Review
2000
Review
2000
Current treatment approaches for neoplastic meningitis: nursing management of patients receiving intrathecal DepoCyt.
PURPOSE/OBJECTIVES To review neoplastic meningitis and the nursing implications for the intrathecal administration of… 
1998
1998
Biodistribution during sustained release from DepoFoam®, a lipid-based parenteral drug delivery system
1997
1997
Treatment of carcinomatous meningiti (CM) with Intra-CFS sustained-release encapsulated cytarablne (DEPOCYT™) vs. Methotrexate (MTX)
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)